ClearPoint Neuro, Inc. (NASDAQ: CLPT) Stock Competitors & Peer Comparison
See CLPT's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CLPT and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CLPT | $14.83 | +1.51% | 444.7M | -12.57 | -$1.18 | N/A |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $101.29 | +0.22% | 175.3B | 19.44 | $5.21 | +2.45% |
| MDT | $88.64 | +0.15% | 113.5B | 16.03 | $5.53 | +3.24% |
| SYK | $272.36 | +0.97% | 104.5B | 20.35 | $13.39 | +1.28% |
| BSX | $43.92 | -1.70% | 65.3B | 14.17 | $3.10 | N/A |
| EW | $86.29 | +0.65% | 49.7B | 31.96 | $2.70 | N/A |
| DXCM | $86.62 | -0.97% | 32.7B | 33.97 | $2.55 | N/A |
| GEHC | $66.63 | +0.38% | 30.1B | 14.61 | $4.56 | +0.21% |
| PHG | $24.96 | +1.67% | 24.4B | 14.26 | $1.75 | +3.97% |
Stock Comparison
Boston Scientific Corporation (NYSE: BSX-PA)
CLPT vs BSX-PA Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, CLPT's ROE is -1.88%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, CLPT is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check BSX-PA's competition here
Abbott Laboratories (NYSE: ABT)
CLPT vs ABT Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, ABT has a market cap of 175.3B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while ABT trades at $101.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas ABT's P/E ratio is 19.44. In terms of profitability, CLPT's ROE is -1.88%, compared to ABT's ROE of +0.11%. Regarding short-term risk, CLPT is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check ABT's competition here
Medtronic plc (NYSE: MDT)
CLPT vs MDT Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, MDT has a market cap of 113.5B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while MDT trades at $88.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas MDT's P/E ratio is 16.03. In terms of profitability, CLPT's ROE is -1.88%, compared to MDT's ROE of +0.11%. Regarding short-term risk, CLPT is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
CLPT vs SYK Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, SYK has a market cap of 104.5B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while SYK trades at $272.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas SYK's P/E ratio is 20.35. In terms of profitability, CLPT's ROE is -1.88%, compared to SYK's ROE of +0.16%. Regarding short-term risk, CLPT is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
CLPT vs BSX Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, BSX has a market cap of 65.3B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while BSX trades at $43.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas BSX's P/E ratio is 14.17. In terms of profitability, CLPT's ROE is -1.88%, compared to BSX's ROE of +0.15%. Regarding short-term risk, CLPT is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
CLPT vs EW Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, EW has a market cap of 49.7B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while EW trades at $86.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas EW's P/E ratio is 31.96. In terms of profitability, CLPT's ROE is -1.88%, compared to EW's ROE of +0.10%. Regarding short-term risk, CLPT is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
CLPT vs DXCM Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, DXCM has a market cap of 32.7B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while DXCM trades at $86.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas DXCM's P/E ratio is 33.97. In terms of profitability, CLPT's ROE is -1.88%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, CLPT is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
CLPT vs GEHC Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, GEHC has a market cap of 30.1B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while GEHC trades at $66.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas GEHC's P/E ratio is 14.61. In terms of profitability, CLPT's ROE is -1.88%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, CLPT is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
CLPT vs PHG Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, PHG has a market cap of 24.4B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while PHG trades at $24.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas PHG's P/E ratio is 14.26. In terms of profitability, CLPT's ROE is -1.88%, compared to PHG's ROE of +0.10%. Regarding short-term risk, CLPT is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
CLPT vs ZBH Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, ZBH has a market cap of 17.6B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while ZBH trades at $91.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas ZBH's P/E ratio is 10.73. In terms of profitability, CLPT's ROE is -1.88%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, CLPT is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
CLPT vs ABMD Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas ABMD's P/E ratio is 65.36. In terms of profitability, CLPT's ROE is -1.88%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, CLPT is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check ABMD's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
CLPT vs SWAV Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas SWAV's P/E ratio is 78.76. In terms of profitability, CLPT's ROE is -1.88%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, CLPT is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
CLPT vs PEN Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while PEN trades at $318.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas PEN's P/E ratio is 83.25. In terms of profitability, CLPT's ROE is -1.88%, compared to PEN's ROE of +0.11%. Regarding short-term risk, CLPT is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
CLPT vs SNN Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, SNN has a market cap of 11.3B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while SNN trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas SNN's P/E ratio is 18.17. In terms of profitability, CLPT's ROE is -1.88%, compared to SNN's ROE of +0.12%. Regarding short-term risk, CLPT is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check SNN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
CLPT vs BIO-B Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, BIO-B has a market cap of 10.5B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while BIO-B trades at $385.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas BIO-B's P/E ratio is -67.89. In terms of profitability, CLPT's ROE is -1.88%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, CLPT is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check BIO-B's competition here
Align Technology, Inc. (NASDAQ: ALGN)
CLPT vs ALGN Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, ALGN has a market cap of 10.5B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while ALGN trades at $146.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas ALGN's P/E ratio is 13.38. In terms of profitability, CLPT's ROE is -1.88%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, CLPT is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
CLPT vs BIO Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, BIO has a market cap of 10.3B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while BIO trades at $381.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas BIO's P/E ratio is 41.05. In terms of profitability, CLPT's ROE is -1.88%, compared to BIO's ROE of +0.03%. Regarding short-term risk, CLPT is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check BIO's competition here
Globus Medical, Inc. (NYSE: GMED)
CLPT vs GMED Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, GMED has a market cap of 10.1B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while GMED trades at $74.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas GMED's P/E ratio is 16.79. In terms of profitability, CLPT's ROE is -1.88%, compared to GMED's ROE of +0.12%. Regarding short-term risk, CLPT is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check GMED's competition here
Bruker Corporation (NASDAQ: BRKR)
CLPT vs BRKR Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, BRKR has a market cap of 9.8B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while BRKR trades at $64.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas BRKR's P/E ratio is 32.25. In terms of profitability, CLPT's ROE is -1.88%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, CLPT is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
CLPT vs BRKRP Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, BRKRP has a market cap of 9.4B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while BRKRP trades at $470.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas BRKRP's P/E ratio is 255.66. In terms of profitability, CLPT's ROE is -1.88%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, CLPT is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check BRKRP's competition here
Insulet Corp. (NASDAQ: PODD)
CLPT vs PODD Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, PODD has a market cap of 9.4B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while PODD trades at $136.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas PODD's P/E ratio is 23.19. In terms of profitability, CLPT's ROE is -1.88%, compared to PODD's ROE of +0.27%. Regarding short-term risk, CLPT is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check PODD's competition here
Masimo Corporation (NASDAQ: MASI)
CLPT vs MASI Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas MASI's P/E ratio is 44.43. In terms of profitability, CLPT's ROE is -1.88%, compared to MASI's ROE of +0.09%. Regarding short-term risk, CLPT is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check MASI's competition here
Glaukos Corporation (NYSE: GKOS)
CLPT vs GKOS Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, GKOS has a market cap of 9.1B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while GKOS trades at $154.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas GKOS's P/E ratio is -180.02. In terms of profitability, CLPT's ROE is -1.88%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, CLPT is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check GKOS's competition here
Haemonetics Corporation (NYSE: HAE)
CLPT vs HAE Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, HAE has a market cap of 4.8B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while HAE trades at $105.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas HAE's P/E ratio is 21.02. In terms of profitability, CLPT's ROE is -1.88%, compared to HAE's ROE of +0.11%. Regarding short-term risk, CLPT is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
CLPT vs NARI Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas NARI's P/E ratio is -59.24. In terms of profitability, CLPT's ROE is -1.88%, compared to NARI's ROE of -0.00%. Regarding short-term risk, CLPT is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
CLPT vs ITGR Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while ITGR trades at $126.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas ITGR's P/E ratio is 19.89. In terms of profitability, CLPT's ROE is -1.88%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, CLPT is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check ITGR's competition here
LivaNova PLC (NASDAQ: LIVN)
CLPT vs LIVN Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while LIVN trades at $76.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas LIVN's P/E ratio is 18.20. In terms of profitability, CLPT's ROE is -1.88%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, CLPT is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check LIVN's competition here
Axonics, Inc. (NASDAQ: AXNX)
CLPT vs AXNX Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas AXNX's P/E ratio is -709.80. In terms of profitability, CLPT's ROE is -1.88%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, CLPT is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check AXNX's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
CLPT vs IRTC Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, IRTC has a market cap of 3.6B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while IRTC trades at $110.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas IRTC's P/E ratio is -256.70. In terms of profitability, CLPT's ROE is -1.88%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, CLPT is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check IRTC's competition here
Neogen Corporation (NASDAQ: NEOG)
CLPT vs NEOG Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, NEOG has a market cap of 3B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while NEOG trades at $13.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas NEOG's P/E ratio is 49.14. In terms of profitability, CLPT's ROE is -1.88%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, CLPT is more volatile compared to NEOG. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check NEOG's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
CLPT vs TMDX Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while TMDX trades at $85.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas TMDX's P/E ratio is 43.29. In terms of profitability, CLPT's ROE is -1.88%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, CLPT is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check TMDX's competition here
Butterfly Network, Inc. (NYSE: BFLY)
CLPT vs BFLY Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, BFLY has a market cap of 2.5B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while BFLY trades at $9.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas BFLY's P/E ratio is -39.13. In terms of profitability, CLPT's ROE is -1.88%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, CLPT is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for CLPT.Check BFLY's competition here
AxoGen, Inc. (NASDAQ: AXGN)
CLPT vs AXGN Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, AXGN has a market cap of 2.3B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while AXGN trades at $43.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas AXGN's P/E ratio is 114.18. In terms of profitability, CLPT's ROE is -1.88%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, CLPT is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
CLPT vs UFPT Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while UFPT trades at $295.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas UFPT's P/E ratio is 30.20. In terms of profitability, CLPT's ROE is -1.88%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, CLPT is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check UFPT's competition here
NuVasive, Inc. (NASDAQ: NUVA)
CLPT vs NUVA Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas NUVA's P/E ratio is 75.00. In terms of profitability, CLPT's ROE is -1.88%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, CLPT is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check NUVA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
CLPT vs INSP Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, INSP has a market cap of 2B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while INSP trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas INSP's P/E ratio is 31.06. In terms of profitability, CLPT's ROE is -1.88%, compared to INSP's ROE of +0.18%. Regarding short-term risk, CLPT is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check INSP's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
CLPT vs ESTA Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, ESTA has a market cap of 1.9B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while ESTA trades at $65.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas ESTA's P/E ratio is -52.36. In terms of profitability, CLPT's ROE is -1.88%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, CLPT is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
CLPT vs NVCR Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, NVCR has a market cap of 1.8B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while NVCR trades at $15.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas NVCR's P/E ratio is -12.18. In terms of profitability, CLPT's ROE is -1.88%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, CLPT is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
CLPT vs ATEC Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while ATEC trades at $10.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas ATEC's P/E ratio is -168.67. In terms of profitability, CLPT's ROE is -1.88%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, CLPT is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for CLPT.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
CLPT vs CNMD Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while CNMD trades at $45.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas CNMD's P/E ratio is 9.97. In terms of profitability, CLPT's ROE is -1.88%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, CLPT is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
CLPT vs HSKA Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas HSKA's P/E ratio is -62.49. In terms of profitability, CLPT's ROE is -1.88%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, CLPT is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
CLPT vs IART Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while IART trades at $16.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas IART's P/E ratio is 6.83. In terms of profitability, CLPT's ROE is -1.88%, compared to IART's ROE of -0.01%. Regarding short-term risk, CLPT is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check IART's competition here
Avanos Medical, Inc. (NYSE: AVNS)
CLPT vs AVNS Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas AVNS's P/E ratio is 27.77. In terms of profitability, CLPT's ROE is -1.88%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, CLPT is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check AVNS's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
CLPT vs SILK Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas SILK's P/E ratio is -18.96. In terms of profitability, CLPT's ROE is -1.88%, compared to SILK's ROE of -0.35%. Regarding short-term risk, CLPT is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check SILK's competition here
Artivion, Inc. (NYSE: AORT)
CLPT vs AORT Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while AORT trades at $22.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas AORT's P/E ratio is 37.75. In terms of profitability, CLPT's ROE is -1.88%, compared to AORT's ROE of -0.01%. Regarding short-term risk, CLPT is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check AORT's competition here
Paragon 28, Inc. (NYSE: FNA)
CLPT vs FNA Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas FNA's P/E ratio is -19.83. In terms of profitability, CLPT's ROE is -1.88%, compared to FNA's ROE of -0.35%. Regarding short-term risk, CLPT is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check FNA's competition here
IRadimed Corporation (NASDAQ: IRMD)
CLPT vs IRMD Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while IRMD trades at $85.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas IRMD's P/E ratio is 43.10. In terms of profitability, CLPT's ROE is -1.88%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, CLPT is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check IRMD's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
CLPT vs TNDM Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while TNDM trades at $15.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas TNDM's P/E ratio is -16.90. In terms of profitability, CLPT's ROE is -1.88%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, CLPT is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for CLPT.Check TNDM's competition here
Enovis Corporation (NYSE: ENOV)
CLPT vs ENOV Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while ENOV trades at $18.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas ENOV's P/E ratio is 5.29. In terms of profitability, CLPT's ROE is -1.88%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, CLPT is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check ENOV's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
CLPT vs LMRI Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, LMRI has a market cap of 981M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while LMRI trades at $10.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas LMRI's P/E ratio is -19.86. In terms of profitability, CLPT's ROE is -1.88%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, CLPT is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check LMRI's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
CLPT vs PRCT Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, PRCT has a market cap of 979M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while PRCT trades at $17.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas PRCT's P/E ratio is -8.87. In terms of profitability, CLPT's ROE is -1.88%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, CLPT is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check PRCT's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
CLPT vs BBNX Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, BBNX has a market cap of 967.7M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while BBNX trades at $21.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas BBNX's P/E ratio is -13.04. In terms of profitability, CLPT's ROE is -1.88%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, CLPT is more volatile compared to BBNX. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check BBNX's competition here
Bioventus Inc. (NASDAQ: BVS)
CLPT vs BVS Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, BVS has a market cap of 935.6M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while BVS trades at $13.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas BVS's P/E ratio is 18.17. In terms of profitability, CLPT's ROE is -1.88%, compared to BVS's ROE of +0.28%. Regarding short-term risk, CLPT is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
CLPT vs CBLL Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, CBLL has a market cap of 898.9M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while CBLL trades at $23.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas CBLL's P/E ratio is -13.46. In terms of profitability, CLPT's ROE is -1.88%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, CLPT is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check CBLL's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
CLPT vs CSII Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas CSII's P/E ratio is -20.83. In terms of profitability, CLPT's ROE is -1.88%, compared to CSII's ROE of -0.14%. Regarding short-term risk, CLPT is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
CLPT vs SIBN Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, SIBN has a market cap of 824.5M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while SIBN trades at $18.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas SIBN's P/E ratio is -54.68. In terms of profitability, CLPT's ROE is -1.88%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, CLPT is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check SIBN's competition here
InMode Ltd. (NASDAQ: INMD)
CLPT vs INMD Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, INMD has a market cap of 819.7M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while INMD trades at $14.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas INMD's P/E ratio is 9.90. In terms of profitability, CLPT's ROE is -1.88%, compared to INMD's ROE of +0.12%. Regarding short-term risk, CLPT is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check INMD's competition here
Varex Imaging Corporation (NASDAQ: VREX)
CLPT vs VREX Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, VREX has a market cap of 776.7M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while VREX trades at $18.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas VREX's P/E ratio is 19.42. In terms of profitability, CLPT's ROE is -1.88%, compared to VREX's ROE of +0.05%. Regarding short-term risk, CLPT is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
CLPT vs AHCO Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, AHCO has a market cap of 767.3M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while AHCO trades at $5.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas AHCO's P/E ratio is 11.51. In terms of profitability, CLPT's ROE is -1.88%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, CLPT is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check AHCO's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
CLPT vs AVR Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, AVR has a market cap of 747.7M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while AVR trades at $7.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas AVR's P/E ratio is -3.96. In terms of profitability, CLPT's ROE is -1.88%, compared to AVR's ROE of -0.78%. Regarding short-term risk, CLPT is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check AVR's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
CLPT vs CTKB Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, CTKB has a market cap of 729.7M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while CTKB trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas CTKB's P/E ratio is -29.93. In terms of profitability, CLPT's ROE is -1.88%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, CLPT is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check CTKB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
CLPT vs SRDX Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas SRDX's P/E ratio is -34.66. In terms of profitability, CLPT's ROE is -1.88%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, CLPT is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check SRDX's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
CLPT vs SSII Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, SSII has a market cap of 590.4M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while SSII trades at $2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas SSII's P/E ratio is -49.17. In terms of profitability, CLPT's ROE is -1.88%, compared to SSII's ROE of -0.27%. Regarding short-term risk, CLPT is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for CLPT.Check SSII's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
CLPT vs APEN Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas APEN's P/E ratio is -9.43. In terms of profitability, CLPT's ROE is -1.88%, compared to APEN's ROE of -0.85%. Regarding short-term risk, CLPT is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check APEN's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
CLPT vs KIDS Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, KIDS has a market cap of 579.2M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while KIDS trades at $22.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas KIDS's P/E ratio is -19.11. In terms of profitability, CLPT's ROE is -1.88%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, CLPT is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check KIDS's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
CLPT vs DCTH Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, DCTH has a market cap of 538.5M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while DCTH trades at $15.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas DCTH's P/E ratio is 1560.00. In terms of profitability, CLPT's ROE is -1.88%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, CLPT is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
CLPT vs ZIMV Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, CLPT's ROE is -1.88%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, CLPT is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
CLPT vs CERS Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, CERS has a market cap of 528M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while CERS trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas CERS's P/E ratio is -87.04. In terms of profitability, CLPT's ROE is -1.88%, compared to CERS's ROE of -0.10%. Regarding short-term risk, CLPT is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check CERS's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
CLPT vs TCMD Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, TCMD has a market cap of 512.7M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while TCMD trades at $22.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas TCMD's P/E ratio is 21.05. In terms of profitability, CLPT's ROE is -1.88%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, CLPT is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check TCMD's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
CLPT vs PACB Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, PACB has a market cap of 503.2M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while PACB trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas PACB's P/E ratio is -3.95. In terms of profitability, CLPT's ROE is -1.88%, compared to PACB's ROE of -49.62%. Regarding short-term risk, CLPT is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for CLPT.Check PACB's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
CLPT vs SGHT Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, SGHT has a market cap of 485.9M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while SGHT trades at $8.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas SGHT's P/E ratio is -15.95. In terms of profitability, CLPT's ROE is -1.88%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, CLPT is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for CLPT.Check SGHT's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
CLPT vs NPCE Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, NPCE has a market cap of 479.4M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while NPCE trades at $14.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas NPCE's P/E ratio is -24.67. In terms of profitability, CLPT's ROE is -1.88%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, CLPT is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check NPCE's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
CLPT vs SENS Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, SENS has a market cap of 417.9M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while SENS trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas SENS's P/E ratio is -4.48. In terms of profitability, CLPT's ROE is -1.88%, compared to SENS's ROE of -1.66%. Regarding short-term risk, CLPT is more volatile compared to SENS. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
CLPT vs OFIX Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, OFIX has a market cap of 381.6M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while OFIX trades at $9.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas OFIX's P/E ratio is -6.15. In terms of profitability, CLPT's ROE is -1.88%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, CLPT is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for CLPT.Check OFIX's competition here
CapsoVision, Inc. (NASDAQ: CV)
CLPT vs CV Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, CV has a market cap of 332.3M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while CV trades at $6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas CV's P/E ratio is -10.56. In terms of profitability, CLPT's ROE is -1.88%, compared to CV's ROE of -1.78%. Regarding short-term risk, CLPT is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for CLPT.Check CV's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
CLPT vs SMLR Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas SMLR's P/E ratio is 3.92. In terms of profitability, CLPT's ROE is -1.88%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, CLPT is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check SMLR's competition here
Avita Medical Inc. (NASDAQ: RCEL)
CLPT vs RCEL Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, RCEL has a market cap of 294.1M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while RCEL trades at $11.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas RCEL's P/E ratio is -8.22. In terms of profitability, CLPT's ROE is -1.88%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, CLPT is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for CLPT.Check RCEL's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
CLPT vs TMCI Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, TMCI has a market cap of 291.9M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while TMCI trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas TMCI's P/E ratio is -4.79. In terms of profitability, CLPT's ROE is -1.88%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, CLPT is more volatile compared to TMCI. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check TMCI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
CLPT vs CATX Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, CATX has a market cap of 286.3M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while CATX trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas CATX's P/E ratio is -1.89. In terms of profitability, CLPT's ROE is -1.88%, compared to CATX's ROE of -0.42%. Regarding short-term risk, CLPT is more volatile compared to CATX. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check CATX's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
CLPT vs TLSI Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, TLSI has a market cap of 267.2M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while TLSI trades at $4.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas TLSI's P/E ratio is -2.58. In terms of profitability, CLPT's ROE is -1.88%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, CLPT is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for CLPT.Check TLSI's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
CLPT vs INFU Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, INFU has a market cap of 257.3M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while INFU trades at $12.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas INFU's P/E ratio is 31.10. In terms of profitability, CLPT's ROE is -1.88%, compared to INFU's ROE of +0.15%. Regarding short-term risk, CLPT is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
CLPT vs MGRM Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas MGRM's P/E ratio is -12.00. In terms of profitability, CLPT's ROE is -1.88%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, CLPT is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
CLPT vs ELMD Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, ELMD has a market cap of 231.4M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while ELMD trades at $27.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas ELMD's P/E ratio is 21.34. In terms of profitability, CLPT's ROE is -1.88%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, CLPT is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
CLPT vs NVRO Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas NVRO's P/E ratio is -1.91. In terms of profitability, CLPT's ROE is -1.88%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, CLPT is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
CLPT vs PROF Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, PROF has a market cap of 209.3M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while PROF trades at $5.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas PROF's P/E ratio is -5.88. In terms of profitability, CLPT's ROE is -1.88%, compared to PROF's ROE of -0.56%. Regarding short-term risk, CLPT is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
CLPT vs RXST Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, RXST has a market cap of 192.9M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while RXST trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas RXST's P/E ratio is -4.12. In terms of profitability, CLPT's ROE is -1.88%, compared to RXST's ROE of -0.17%. Regarding short-term risk, CLPT is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check RXST's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
CLPT vs BSGM Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas BSGM's P/E ratio is -5.81. In terms of profitability, CLPT's ROE is -1.88%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, CLPT is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for CLPT.Check BSGM's competition here
Neuronetics, Inc. (NASDAQ: STIM)
CLPT vs STIM Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, STIM has a market cap of 190.7M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while STIM trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas STIM's P/E ratio is -6.23. In terms of profitability, CLPT's ROE is -1.88%, compared to STIM's ROE of -1.51%. Regarding short-term risk, CLPT is more volatile compared to STIM. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check STIM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
CLPT vs MDGS Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas MDGS's P/E ratio is -0.27. In terms of profitability, CLPT's ROE is -1.88%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, CLPT is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for CLPT.Check MDGS's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
CLPT vs FOCL Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, FOCL has a market cap of 176.5M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while FOCL trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas FOCL's P/E ratio is -4.55. In terms of profitability, CLPT's ROE is -1.88%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, CLPT is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check FOCL's competition here
Quantum-Si incorporated (NASDAQ: QSI)
CLPT vs QSI Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, QSI has a market cap of 165M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while QSI trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas QSI's P/E ratio is -1.81. In terms of profitability, CLPT's ROE is -1.88%, compared to QSI's ROE of -0.47%. Regarding short-term risk, CLPT is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for CLPT.Check QSI's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
CLPT vs QIPT Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas QIPT's P/E ratio is -15.87. In terms of profitability, CLPT's ROE is -1.88%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, CLPT is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check QIPT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
CLPT vs LUCD Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, LUCD has a market cap of 157.6M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while LUCD trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas LUCD's P/E ratio is -2.23. In terms of profitability, CLPT's ROE is -1.88%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, CLPT is more volatile compared to LUCD. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check LUCD's competition here
Quanterix Corporation (NASDAQ: QTRX)
CLPT vs QTRX Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, QTRX has a market cap of 154M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while QTRX trades at $3.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas QTRX's P/E ratio is -1.29. In terms of profitability, CLPT's ROE is -1.88%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, CLPT is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for CLPT.Check QTRX's competition here
Inogen, Inc. (NASDAQ: INGN)
CLPT vs INGN Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, INGN has a market cap of 145.1M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while INGN trades at $5.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas INGN's P/E ratio is -5.89. In terms of profitability, CLPT's ROE is -1.88%, compared to INGN's ROE of -0.13%. Regarding short-term risk, CLPT is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check INGN's competition here
iCAD, Inc. (NASDAQ: ICAD)
CLPT vs ICAD Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas ICAD's P/E ratio is -20.37. In terms of profitability, CLPT's ROE is -1.88%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, CLPT is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check ICAD's competition here
electroCore, Inc. (NASDAQ: ECOR)
CLPT vs ECOR Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, ECOR has a market cap of 100.3M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while ECOR trades at $11.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas ECOR's P/E ratio is -6.62. In terms of profitability, CLPT's ROE is -1.88%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, CLPT is more volatile compared to ECOR. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check ECOR's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
CLPT vs HJLI Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas HJLI's P/E ratio is N/A. In terms of profitability, CLPT's ROE is -1.88%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, CLPT is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check HJLI's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
CLPT vs ASXC Comparison September 2026
ClearPoint Neuro, Inc. (NASDAQ: CLPT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLPT stands at 444.7M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, CLPT is priced at $14.83 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLPT currently has a P/E ratio of -12.57, whereas ASXC's P/E ratio is -1.12. In terms of profitability, CLPT's ROE is -1.88%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, CLPT is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for CLPT.Check ASXC's competition here